Related Experiment Video
Updated: Mar 9, 2026
05:33
Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
Published on: August 4, 2023
2.4K
Treatment options for hyperemesis gravidarum
Amy Abramowitz1, Emily S Miller2, Katherine L Wisner2
1UIC Department of Psychiatry, University of Illinois at Chicago, 912 S. Wood Street, Chicago, IL, 60612, USA. abramowitza@gmail.com.
Archives of Women'S Mental Health
|January 11, 2017
Summary
Mirtazapine shows promise for treating hyperemesis gravidarum (HG), a severe pregnancy nausea and vomiting condition. Further research is needed to confirm its efficacy and expand treatment options for affected women.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Maternal-Fetal Medicine
Background:
- Hyperemesis gravidarum (HG) is a severe pregnancy complication affecting 0.3-2% of pregnancies.
- Characterized by dehydration, ketonuria, and significant weight loss, HG necessitates effective management.
- Current treatments, including doxylamine/pyridoxine and antiemetics, have limitations for some patients.
Purpose of the Study:
- To explore the potential of mirtazapine as an effective treatment for hyperemesis gravidarum.
- To evaluate mirtazapine's pharmacological profile in the context of HG management.
- To assess the safety profile of mirtazapine regarding birth defects in HG patients.
Main Methods:
- Review of existing case studies and pharmacological data on mirtazapine.
- Analysis of mirtazapine's mechanism of action on relevant neurotransmitter systems.
- Examination of safety data concerning teratogenicity and pregnancy outcomes.
Main Results:
- Mirtazapine demonstrates a multi-receptor action (noradrenergic, serotonergic, histaminergic, muscarinic) contributing to antiemetic effects.
- Case studies suggest mirtazapine's efficacy in managing HG symptoms.
- Mirtazapine is not linked to an independent increased risk of birth defects.
Conclusions:
- Mirtazapine presents a promising therapeutic option for women with hyperemesis gravidarum refractory to standard treatments.
- Its multifaceted pharmacological actions may address HG symptoms effectively.
- Further clinical investigation is warranted to establish mirtazapine's role in expanding HG treatment paradigms.
Keywords:
Gastrointestinal disorders in pregnancyHyperemesisHyperemesis gravidarumMirtazapineNausea and vomiting in pregnancyMore Related Videos
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
755
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
755
01:22Methods of reducing fever
1.5K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
1.5K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
818
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
818
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
995
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
995
01:14Prevention of Further Absorption of Poison
1.3K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.3K
01:26Pharmaceutical Poisoning: Treatment Strategies
103
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
103